Market Tracker

01/18 3:09pm ET
0.6605
BATS BZX Real-Time Price
As of 3:08pm ET
 -0.0195 / -2.87%
Today’s Change
0.41
Today|||52-Week Range
2.24
+3.74%
Year-to-Date
Insulin Drug Offers Hope for MannKind
Jan 12 / TheStreet.com - Paid Partner Content
Is MannKind Corp. Ready to Rebound in 2017?
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.68
Today’s open0.67
Day’s range0.66 - 0.68
Volume64,986
Average volume (3 months)4,727,543
Market cap$325.3M
Dividend yield--
Data as of 3:08pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+113.19%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc-0.10-1.61%
CRBPCorbus Pharmaceutica...-0.10-1.36%
NLNKNewLink Genetics Cor...-0.10-0.90%
PRTKParatek Pharmaceutic...-0.25-1.72%
Data as of 3:06pm ET, 01/18/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts